Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiming Guo

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Nature|January 7, 2026
Intratumoural vaccination via checkpoint degradation-coupled antigen presentationYu Han, Yicong Ma, Miao Pei, et al.
NPJ Regenerative Medicine|July 1, 2026
Multi-omics profiling reveals systemic rejuvenation of the aged kidney through senolytic therapyShilin Chen, Chenglin Zhang, Pengxu Cang, et al.
Cell|November 6, 2024
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironmentFeng Lin, Shenyi Yin, Zijian Zhang, et al.
Cell|June 25, 2026
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironmentFeng Lin, Shenyi Yin, Zijian Zhang, et al.
Cell Reports. Medicine|November 20, 2025
Precision prediction of venetoclax-azacitidine treatment efficacy in acute myeloid leukemia via integrative drug screening and machine learningPeng Jin, Dan Wang, Jie Shen, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Nature|January 7, 2026
Intratumoural vaccination via checkpoint degradation-coupled antigen presentationYu Han, Yicong Ma, Miao Pei, et al.
NPJ Regenerative Medicine|July 1, 2026
Multi-omics profiling reveals systemic rejuvenation of the aged kidney through senolytic therapyShilin Chen, Chenglin Zhang, Pengxu Cang, et al.
Cell|November 6, 2024
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironmentFeng Lin, Shenyi Yin, Zijian Zhang, et al.
Cell|June 25, 2026
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironmentFeng Lin, Shenyi Yin, Zijian Zhang, et al.
Cell Reports. Medicine|November 20, 2025
Precision prediction of venetoclax-azacitidine treatment efficacy in acute myeloid leukemia via integrative drug screening and machine learningPeng Jin, Dan Wang, Jie Shen, et al.
Pageof 6